Table 6. Predictors of death or intubation.

Final models using the type of glucocorticoid therapy.

Variable	HR (95%CI)	p
WHOLE COHORT (n = 242)
Glucocorticoid therapy
No glucocorticoids	reference
Non-pulse glucocorticoids	3.83 (1.51–9.68)	0.004
Out-of-week-2-MP	2.06 (0.71–6.00)	0.183
Week-2-MP	0.28 (0.07–1.12)	0.072
SpO2/FiO2*	0.92 (0.89–0.95)	<0.001
CURB65
Low risk	reference
Intermediate risk	2.38 (1.00–5.65)	0.049
High risk	3.98 (1.58–9.89)	0.003
PATIENTS WITH SpO2/FiO2 ≤353 (n = 122)
Glucocorticoid therapy
No glucocorticoids	reference
Non-pulse glucocorticoids	3.06 (1.06–8.85)	0.039
Out-of-week-2-MP	1.92 (0.61–6.00)	0.263
Week-2-MP	0.20 (0.04–1.00)	0.050
SpO2/FiO2*	0.88 (0.83–0.93)	<0.001
CURB65
Low risk	reference
Intermediate risk	2.49 (0.91–6.80)	0.075
High risk	5.00 (1.73–14.47)	0.003

MP: methyl-prednisolone pulses; Week-2-MP: methyl-prednisolone pulses in week 2. HR: hazard ratio; CI: confidence interval.

*HR here estimates change in hazard by 10 units increase in SaO2/FiO2.